Vertaling van "economic inequalities in health " (Frans → Nederlands) :

106. Mackenbach JP, Kunst AE. Measuring the magnitude of socio- economic inequalities in health: an overview of available measures illustrated with two examples from Europe. Social science &
106. Mackenbach JP, Kunst AE. Measuring the magnitude of socio- economic inequalities in health: an overview of available measures

Auteurs : Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Institut Scientifique de Santé Publique), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Mutualité chrétienne), Michael Callens (Mutualité chrétienne), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).
Auteurs: Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Wetenschappelijk Instituut Volksgezondheid), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Christelijke Mutualiteit), Michael Callens (Christelijke Mutualiteit), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).

le guide des stimulants économiques: How to create economic incentives in occupational safety and health: A practical guide
de gids voor economische stimulansen: How to create economic incentives in occupational safety and health: A practical guide

Lire le document en anglais sur le site web de l'Agence européenne pour la sécurité et la santé au travail: Report - Occupational safety and health and economic performance in small and medium-sized enterprises: a review
Lees het werkdocument in het Engels op de website van het Europees Agentschap voor veiligheid en gezondheid op het werk: Report - Occupational safety and health and economic performance in small and medium-sized enterprises: a review

le rapport complet en anglais: Economic incentives to improve occupational safety and health: a review from the European perspective
het volledig rapport in het Engels: Economic incentives to improve occupational safety and health: a review from the European perspective

105 To assesss the progress towards reducing social inequalities in health, it is important to measure them 100 ,
105 To assesss the progress towards reducing social inequalities in health, it is important to measure them 100 , and to monitor if they change over time (by repeating those measurements) ).

8.2.2.2 Inequalities in the indicators of accessibility The percentage of households reporting to have delayed contacts with the health system for financial reasons was strongly related to the income level, with 27% of delay in the households of the lowest quintile versus 4%
114 These data are not presented in detail in this report. 8.2.2.2 Inequalities in the indicators of accessibility The percentage of households reporting to have delayed contacts with the health system for financial reasons was strongly related to the income level, with 27% of delay in the households of the lowest quintile versus 4%

one or more synthetic inequality measures in the health-related indicator(s).
The measurement of health inequalities requires choosing:

Beutels Philippe (University Antwerp), Dewilde Sarah MSc (Health Care Analytics Group, United BioSource Corporation), Lamers Leida (iMTA and Erasmus University Medical Center, NL), Robays Hugo (UGent), Rumeau- Pichon Catherine (Health economics and public health (HAS), FR), Simoens Steven (KULeuven), Van Eeckhout Herman (Pharma.be).
Prof. Dr. Beutels Philippe (University Antwerp), Ms. Dewilde Sarah MSc (Health Care Analytics Group, United BioSource Corporation), Dr. Lamers Leida (iMTA and Erasmus University Medical Center, NL), Prof. Dr. Robays Hugo (UGent), Mrs. Rumeau-Pichon Catherine (Health economics and public health (HAS), FR), Prof. Dr. Simoens Steven (KULeuven), Dr. Van Eeckhout Herman (Pharma.be).

MeSH: Cost-Benefit Analysis ; Decision Making ; Health Care Rationing / economics ; Quality- Adjusted Life Years ; Health Care Costs
MeSH : Cost-Benefit Analysis ; Decision Making ; Health Care Rationing / economics ; Quality- Adjusted Life Years ; Health Care Costs